Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE)
The prototype ORACLE scale based on two simple measures of type 2 airway inflammation (blood eosinophils and FENO) quantifies the excess risk conferred by raised biomarkers that is removed by type-2 anti-inflammatory treatment in trial populations
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
European Respiratory Society
2022
|
| _version_ | 1826307415871586304 |
|---|---|
| author | Couillard Castonguay, S Do, WI Beasley, R Hinks, T Pavord, I |
| author_facet | Couillard Castonguay, S Do, WI Beasley, R Hinks, T Pavord, I |
| author_sort | Couillard Castonguay, S |
| collection | OXFORD |
| description | The prototype ORACLE scale based on two simple measures of type 2 airway inflammation (blood eosinophils and FENO) quantifies the excess risk conferred by raised biomarkers that is removed by type-2 anti-inflammatory treatment in trial populations |
| first_indexed | 2024-03-07T07:02:48Z |
| format | Journal article |
| id | oxford-uuid:26b6a1cf-4ad0-49dd-9e3f-1457c44719c1 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:02:48Z |
| publishDate | 2022 |
| publisher | European Respiratory Society |
| record_format | dspace |
| spelling | oxford-uuid:26b6a1cf-4ad0-49dd-9e3f-1457c44719c12022-04-14T11:53:41ZPredicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE)Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:26b6a1cf-4ad0-49dd-9e3f-1457c44719c1EnglishSymplectic ElementsEuropean Respiratory Society2022Couillard Castonguay, SDo, WIBeasley, RHinks, TPavord, IThe prototype ORACLE scale based on two simple measures of type 2 airway inflammation (blood eosinophils and FENO) quantifies the excess risk conferred by raised biomarkers that is removed by type-2 anti-inflammatory treatment in trial populations |
| spellingShingle | Couillard Castonguay, S Do, WI Beasley, R Hinks, T Pavord, I Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE) |
| title | Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE) |
| title_full | Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE) |
| title_fullStr | Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE) |
| title_full_unstemmed | Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE) |
| title_short | Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE) |
| title_sort | predicting the benefits of type 2 targeted anti inflammatory treatment with the prototype oxford asthma attack risk scale oracle |
| work_keys_str_mv | AT couillardcastonguays predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle AT dowi predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle AT beasleyr predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle AT hinkst predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle AT pavordi predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle |